Immunotherapy plus chemotherapy before surgery improves outcomes for lung cancer patients
Adding the immunotherapy drug nivolumab to chemotherapy before surgery (neoadjuvant) for patients with operable non-small cell lung cancer (NSCLC) —…
Adding the immunotherapy drug nivolumab to chemotherapy before surgery (neoadjuvant) for patients with operable non-small cell lung cancer (NSCLC) —…
Lung cancer is a major global cause of mortality, reportedly accounting for 1.7 million deaths each year. The most common…
Scientists at VCU Massey Cancer Center have identified a protein that operates in tandem with a specific genetic mutation to…